Turtlemint Fintech IPO Listing Preview: GMP ₹2, Expected Listing ₹154 — Sell or Hold Analysis

The Turtlemint Fintech IPO listing date is approaching as shortly after the subscription period closes. Based on the current Turtlemint Fintech IPO GMP of ₹2 per share, the indicative listing price is approximately ₹154, representing a marginal gain of about 1.3-1.5% over the upper price band of ₹152. The grey market premium has remained steady in the ₹2-2.25 range throughout the subscription window, signalling muted but positive market expectations for the Turtlemint Fintech IPO listing. The issue raised ₹882.67 crore at ₹144-152 per share and was listed on both BSE and NSE.

Turtlemint Fintech Solutions Limited, founded in 2015 and promoted by Anand Prabhudesai and Dhirendra Mahyavanshi, is a technology-enabled insurance distribution platform that operates the largest certified PoSP (Point-of-Sale Person) network in India by some metrics. As of December 2025, the platform had 6.3 lakh digital partners operating across 19,171 PIN codes, covering approximately 98% of India’s postal network. The company facilitated 21.87 million insurance policies between April 2022 and December 2025. Revenue grew 481% from ₹119.12 crore in FY24 to ₹693.21 crore in FY25. However, the company remains loss-making (net loss of ₹194.11 crore in FY25) and has seen its net worth decline to ₹295.68 crore as of December 2025. Ankit Jaiswal, Senior Research Analyst at Univest notes that the modest Turtlemint Fintech IPO listing expectation reflects the market’s caution about the path to profitability for a high-growth but loss-making insurtech platform.

Click Here – Get Free IPO Investment Insights

Turtlemint Fintech IPO Listing Details: Complete Snapshot

Parameter	Details
Issue Type	Book Built Issue — Mainboard (BSE + NSE)
Price Band	₹144 to ₹152 per share
Lot Size	98 shares (1 lot = 98 shares)
Minimum Investment	₹14,896 (at upper price band)
Issue Size	₹882.67 Crore (Fresh ₹660.72 Cr + OFS ₹221.95 Cr)
GMP Today	₹2 (~1.5% over upper band)
Expected Listing Price	~₹154 per share
Expected Listing Gain	~1.3-1.5%
Exchange	BSE + NSE (Mainboard)
Registrar	KFin Technologies Ltd.
Lead Managers	ICICI Securities, Jefferies, JM Financial, Motilal Oswal

What to Expect on Turtlemint Fintech IPO Listing Day

The Turtlemint Fintech IPO listing GMP of ₹2 signals the market expects a flat to marginally positive debut on the exchanges. This is consistent with the company’s mixed investor profile: strong revenue growth and market leadership in the PoSP insurance distribution segment on one hand, and persistent losses, declining net worth, and negative operating cash flows on the other. The anchor allocation — ₹397.20 crore from 32 institutions including mutual funds, insurance companies, and foreign portfolio investors — confirms institutional conviction in the long-term growth story, but the modest subscription response (overall subscription was weak in retail and NII categories, with QIBs driving the final oversubscription) explains the flat GMP for the Turtlemint Fintech IPO listing day.

About Turtlemint Fintech Solutions

Turtlemint operates a phygital (physical + digital) insurance distribution model connecting insurers, digital partners (PoSP agents), and customers. The platform provides comparison tools, lead management, training, and claims support to its 6.3 lakh digital partners, who then distribute insurance policies from 45 insurer partners to end customers. The company focuses heavily on B30+ markets (beyond India’s top 30 cities), with 80% of its digital partners and 75% of platform premium coming from these underserved markets. Its revenue from operations grew from ₹662.71 crore in FY25 (from ₹78.64 crore in FY24) to ₹741.07 crore in 9M FY26, driven by the rapid expansion of its PoSP network.

Turtlemint Fintech IPO: Key Financials

Revenue (total income) grew from ₹119.12 crore in FY24 to ₹693.21 crore in FY25, a 481% increase. Net loss was ₹194.11 crore in FY25 vs ₹193.35 crore in FY24 — loss quantum unchanged despite massive revenue growth, signalling heavy reinvestment. For 9M FY26, revenue reached ₹748.91 crore with net loss of ₹187.39 crore. Net worth has been declining due to accumulated losses: from ₹743.5 crore in FY23 to ₹410.46 crore in FY25 and ₹295.68 crore in 9M FY26. Return on net worth (RoNW) was a negative 47.29% in FY25, reflecting sustained losses against a shrinking equity base.

Turtlemint Fintech IPO Listing Day: Sell or Hold?

Track Turtlemint Fintech IPO Listing and All IPO Data on Univest Screener

Given the Turtlemint Fintech IPO listing GMP implies only a 1-1.5% gain, investors who received allotment face a straightforward calculation: with marginal expected listing gains and the company still loss-making, the risk-reward for immediate selling at listing versus holding for medium-term growth depends on one’s conviction in the insurtech / PoSP model. Investors who believe India’s insurance penetration will grow significantly and that Turtlemint will achieve profitability as the network matures may prefer to hold. Those who want to redeploy capital or reduce exposure to pre-profitability growth stocks may prefer to book the modest gain on listing. Consult a SEBI-registered financial advisor before making a listing-day decision.

Turtlemint Fintech IPO Listing: Conclusion and Final Verdict

The Turtlemint Fintech IPO listing is expected at approximately ₹154, implying a modest 1.5% gain over the issue price based on the current GMP of ₹2. The company’s rapid revenue growth (481% in FY25) and dominant PoSP platform position are offset by persistent losses and declining net worth, making this a medium-to-long-term story rather than a listing-day play. Track Turtlemint Fintech IPO listing price and post-listing performance on Univest. Consult a SEBI-registered financial advisor before making investment decisions.

Download the Univest iOS App or Univest Android App to track Turtlemint Fintech IPO listing price and performance live on Univest.

Frequently Asked Questions

What is the Turtlemint Fintech IPO listing price expected to be?

Ans. Based on the current Turtlemint Fintech IPO GMP of ₹2, the expected listing price is approximately ₹154 per share — a gain of about 1.3-1.5% over the upper price band of ₹152. The GMP has been stable in the ₹2-2.25 range, signalling a flat to marginally positive listing. The Turtlemint Fintech IPO listing reflects the current grey market sentiment for this issue.

What is the Turtlemint Fintech IPO GMP?

Ans. The Turtlemint Fintech IPO GMP is ₹2 per share as the subscription window closes. This implies an expected listing around ₹154. GMP is unofficial and unregulated; actual listing price will depend on market sentiment, broader Nifty 50 levels, and order book dynamics on listing day. The Turtlemint Fintech IPO listing reflects the current grey market sentiment for this issue.

What does Turtlemint do?

Ans. Turtlemint Fintech Solutions is an insurtech platform enabling insurance distribution through a network of 6.3 lakh certified PoSP (Point-of-Sale Person) digital partners. The platform connects these partners with 45 insurer partners across life, health, motor, and other insurance segments. Turtlemint covers 19,171 PIN codes and focuses on B30+ underserved markets across India. The Turtlemint Fintech IPO listing reflects the current grey market sentiment for this issue.

Is Turtlemint Fintech Solutions profitable?

Ans. No. Turtlemint Fintech Solutions reported a net loss of ₹194.11 crore in FY25 and ₹187.39 crore in 9M FY26, despite rapid revenue growth. The company has been loss-making for at least three consecutive financial years. Net worth has been declining due to accumulated losses, reaching ₹295.68 crore as of December 2025 from ₹743.5 crore in FY23.

What was the Turtlemint Fintech IPO subscription status?

Ans. The Turtlemint Fintech IPO had muted retail and NII subscription initially, with QIB and anchor investors driving the overall picture. Anchor allocation of ₹397.20 crore from 32 institutions was strong, including ICICI Prudential, Axis Max Life Insurance, BNP Paribas, and Nomura Singapore. Final overall subscription ratios will be available after the subscription closes.

Should I sell Turtlemint IPO on listing?

Ans. With only ~1.5% expected listing gain based on current GMP, the margin to sell on listing is minimal. Investors with high transaction costs (brokerage, STT, exchange charges) may not benefit significantly from selling immediately. Those with medium-term conviction in India’s insurance distribution growth and Turtlemint’s path to profitability may prefer to hold. Consult a SEBI-registered financial advisor.

Who are Turtlemint’s insurer partners?

Ans. Turtlemint has partnerships with 45 insurance companies across life, health, motor, and general insurance segments. Key names include major private and public sector insurers in India. The breadth of insurer partnerships allows Turtlemint’s digital partners to offer comparison and choice to customers, which is a key differentiator of its distribution model.

What is PoSP in insurance?

Ans. PoSP (Point of Sale Person) is a SEBI-regulated category of insurance intermediary introduced by IRDAI that allows individuals with minimal qualifications to sell simple insurance products after completing a training and certification process. Turtlemint was among the first platforms to adopt and scale the PoSP model in India, building one of the country’s largest certified PoSP networks with 6.3 lakh digital partners as of December 2025.